Municipal Employees Retirement System of Michigan Sells 6,490 Shares of UnitedHealth Group Inc (UNH)
Municipal Employees Retirement System of Michigan reduced its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 13.5% during the third quarter, Holdings Channel reports. The fund owned 41,620 shares of the healthcare conglomerate’s stock after selling 6,490 shares during the period. UnitedHealth Group comprises about 0.4% of Municipal Employees Retirement System of Michigan’s investment portfolio, making the stock its 18th biggest position. Municipal Employees Retirement System of Michigan’s holdings in UnitedHealth Group were worth $8,151,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $121,000. Finally, Acrospire Investment Management LLC grew its holdings in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 86.01% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) opened at $225.39 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $217,920.00, a price-to-earnings ratio of 25.61, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a 52-week low of $156.09 and a 52-week high of $231.77.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.17 earnings per share. equities research analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
A number of brokerages recently commented on UNH. Goldman Sachs Group began coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price target on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $226.74.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last three months. Insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.